• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2019)
elshamy, S., omar, O., massoud, M. (2020). LEVELS OF FECAL CALPROTECTIN AND ALPHA ONE ANTITRYPSIN IN CHILDREN WITH STUNTING. ALEXMED ePosters, 2(2), 15-16. doi: 10.21608/alexpo.2020.40943.1017
samar ismail elshamy; omnia magdyy omar; mohamed zaki massoud. "LEVELS OF FECAL CALPROTECTIN AND ALPHA ONE ANTITRYPSIN IN CHILDREN WITH STUNTING". ALEXMED ePosters, 2, 2, 2020, 15-16. doi: 10.21608/alexpo.2020.40943.1017
elshamy, S., omar, O., massoud, M. (2020). 'LEVELS OF FECAL CALPROTECTIN AND ALPHA ONE ANTITRYPSIN IN CHILDREN WITH STUNTING', ALEXMED ePosters, 2(2), pp. 15-16. doi: 10.21608/alexpo.2020.40943.1017
elshamy, S., omar, O., massoud, M. LEVELS OF FECAL CALPROTECTIN AND ALPHA ONE ANTITRYPSIN IN CHILDREN WITH STUNTING. ALEXMED ePosters, 2020; 2(2): 15-16. doi: 10.21608/alexpo.2020.40943.1017

LEVELS OF FECAL CALPROTECTIN AND ALPHA ONE ANTITRYPSIN IN CHILDREN WITH STUNTING

Article 9, Volume 2, Issue 2, October 2020, Page 15-16  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2020.40943.1017
View on SCiNiTO View on SCiNiTO
Authors
samar ismail elshamy email 1; omnia magdyy omar1; mohamed zaki massoud2
1pediatric alexandira university
2pediatric faculty of medicine alexandria
Abstract
Stunting is the impaired growth and development that children experience from poor nutrition, repeated infection, and inadequate psychosocial stimulation. Children are defined as stunted if their height-for-age is more than two standard deviations below the WHO Child Growth Standards median.
Stunting in early life -- particularly in the first 1000 days from conception until the age of two - impaired growth has adverse functional consequences on the child. Some of those consequences include poor cognition and educational performance, low adult wages, lost productivity and, when accompanied by excessive weight gain later in childhood, an increased risk of nutrition-related chronic diseases in adult life.
Childhood stunting is considered the best overall indicator of children’s well-being and an accurate reflection of social inequalities in communitie.
In 2010, it was found that 171 million child was stunted compared to 167 million in developing countries. Globally, childhood stunting decreased from 39.7% in 1990 to 26.7% in 2010. This trend is expected to reach 21•8 %, or 142 million, in 2020.
In Egypt: the incidence of children with stunting is 21.4%.-
Keywords
stunting; calprotectin; A1AT
Statistics
Article View: 338
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.